NYSE$SCL

Stepan Company · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Briefing

Stepan's Q1 2024 results were reported, showing a decrease in net income but an increase in adjusted EBITDA.

Stepan Company reported a decrease in net income but an increase in adjusted EBITDA for Q1 2024. The company is on track to deliver its $50 million cost out goal for the year and recognized $18 million in pre-tax savings in the first quarter. Global sales volume was up 1%, and cash from operations was $41.6 million.

  • Net income was reported at $13.9 million, with adjusted net income down 11% year-over-year due to a higher effective tax rate.
  • Adjusted EBITDA was $51.2 million, a 5% increase year-over-year.
  • Global sales volume increased by 1%, or 4% excluding declines in Agricultural and commodity Phthalic Anhydride businesses.
  • Cash from Operations reached $41.6 million, with free cash flow at $11.4 million as capital expenditures returned to historical levels.

Headline financials

Total Revenue

$551M

Previous: $651M-15.4%
EPS

$0.61

Previous: $0.71-14.1%
Surfactant Operating Income

$26.1M

No prior period
Polymer Operating Income

$8.38M

No prior period
Specialty Product Op Income

$4.27M

No prior period
Corporate Expenses

$18.6M

No prior period
Adjusted Net Income

$14.7M

No prior period
EBITDA

$50.2M

Previous: $48.3M+3.9%
Adjusted EBITDA

$51.2M

Previous: $48.7M+5.1%
Total Debt

$625M

No prior period
Net Debt

$526M

No prior period
Net Debt / (Net Debt + Equity)

31.0%

No prior period
Net Receivables

$388M

No prior period
Inventories

$289M

No prior period
Accounts Payable

$259M

No prior period
Capital Expenditures

-$30.2M

Previous: -$92.2M+67.3%
Free Cash Flow

-$16.3M

Previous: -$76M+78.6%
Net Income

$13.9M

Previous: $16.1M-13.9%
Operating Income

$20.2M

Previous: $21.1M-4.2%
Gross Profit

$70.3M

Previous: $73.6M-4.5%
Cash & Equivalents

$126M

Previous: $127M-0.9%
Total Assets

$2.37B

Previous: $2.45B-3.0%
R&D Expense

$14.3M

No prior period
Stock-Based Comp

$1.37M

Previous: $999K+37.3%

Revenue & EPS history

Stepan · Revenue · Quarterly

$551M

Q1 2024-15.4%vs Q1 2023
Beat estimate in 9 of 15 quarters(60%)
ActualEstimate

Revenue by segment

Stepan · $562M total across 3 segments · Q3 2023

  • Surfactants
    $374M-21.3%
  • Polymers
    $170M-21.1%
  • Specialty Products
    $18.8M-36.2%

Forward guidance

Stepan anticipates gradual improvements in sales volumes due to ongoing recovery in Rigid Polyols and growth in Surfactant volumes, including the expected recovery of the Agricultural business in the second half of the year. The company remains focused on cost reduction and expects free cash flow to improve.

Tailwinds

  • Sales volumes are expected to gradually improve due to ongoing recovery in Rigid Polyols.
  • Growth in Surfactant volumes is anticipated.
  • The Agricultural business is expected to recover in the second half of the year.
  • The company is focused on delivering $50 million in pre-tax savings from its cost reduction program.
  • Free cash flow should continue to improve versus prior year.

Headwinds

  • Inflationary pressures are expected to continue.
  • Increased expenses are associated with the commissioning of the new Pasadena alkoxylation assets.
  • Higher incentive-based compensation expenses are anticipated.
  • Expenses are associated with the operational issues at the Millsdale site.
  • Operational performance needs to improve.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2024

Historical avgQ1 2024

-0.5%

Avg return

Earnings day

-1.1%

Avg return

5 days after

-0.7%

Avg return

30 days after

43%

28 / 65 earnings

Positive

+12.4%

Q1 2015

Best reaction

-20.4%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+1.1%-0.7%-2.7%
Q4 2025-20.4%-24.3%-25.2%
Q3 2025-0.4%-4.1%+2.2%
Q1 2025+7.1%+13.8%+15.2%
Q4 2024+0.1%-0.0%-7.3%
Q3 2024-0.8%-0.2%+5.4%
Q2 2024-11.0%-18.9%-13.8%
Q1 2024-0.6%+1.4%+0.2%
Q4 2023-2.5%-2.3%-3.2%
Q3 2023+7.9%+9.1%+18.7%
Q2 2023-3.8%-0.6%-10.1%
Q1 2023-10.2%-7.2%-5.8%
Q4 2022-2.4%-4.5%-13.3%
Q3 2022-2.9%-0.3%+10.5%
Q2 2022+8.6%+5.4%+2.0%
Q1 2022+4.9%+3.9%+11.7%
Q4 2021-3.5%-5.6%-9.7%
Q3 2021+2.4%+1.2%+1.9%
Q2 2021-0.1%+0.2%-1.0%
Q1 2021-0.7%-0.8%+2.1%
Q4 2020-2.9%-2.1%+4.7%
Q3 2020-0.5%+2.0%+7.0%
Q2 2020+7.5%+7.6%+12.8%
Q1 2020-1.9%-0.3%+4.8%
Q4 2019-1.6%-8.3%-26.6%
Q3 2019+0.1%+3.6%+1.4%
Q2 2019+3.7%+3.2%-2.0%
Q1 2019-0.2%-0.2%-6.2%
Q4 2018+1.5%+0.9%-7.7%
Q3 2018+3.0%+1.0%-2.1%
Q2 2018+5.3%+6.4%+8.8%
Q1 2018-17.2%-18.5%-20.0%
Q4 2017+5.8%+10.3%+11.3%
Q3 2017-7.0%-7.3%-4.3%
Q2 2017-7.2%-10.2%-15.9%
Q1 2017+9.7%+4.8%+7.4%
Q4 2016-10.3%-5.9%-0.7%
Q3 2016+6.6%+2.9%+11.9%
Q2 2016+4.2%+2.4%+11.6%
Q1 2016+6.6%
Q4 2015+12.0%
Q3 2015+8.8%
Q2 2015-10.6%
Q1 2015+12.4%
Q4 2014-0.6%
Q3 2014-5.2%
Q2 2014-1.5%
Q1 2014-1.7%
Q4 2013-5.1%
Q3 2013+0.6%
Q2 2013+0.7%
Q1 2013-11.4%
Q2 2010-0.5%
Q4 2012-0.1%
Q3 2012-3.8%
Q2 2012-8.0%
Q1 2011+3.6%
Q1 2012+3.9%
Q4 2009+4.7%
Q4 2011+4.7%
Q3 2011-4.5%
Q3 2010-4.5%
Q4 2010-2.0%
Q2 2011-2.0%
Q1 2010+1.7%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro